The Heart Rhythm Society (HRS) announced on Monday that it has formed a collaboration with Milestone Pharmaceuticals, an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines for certain heart conditions.

The partners aim to expand supraventricular tachycardia (SVT) patient education through UpBeat.org, HRS's patient education platform.

New resources available at UpBeat.org/SVT include: a downloadable SVT patient information sheet; videos explaining the causes, symptoms, and diagnosis of SVT as well as treatment approaches; and a new interview 'Understanding SVT: What Patients and EPs Want Each Other to Know'.